In AML there is evidence of a coordinated alterations in IDH2 (epigenetic regulator) and SRSF2 (splicing factor), resulting in distinct splicing changes and increased stalling of RNA polymerase II [51]. This evidence concerns the gene IDH2 and acute myeloid leukemia.